Cephalon Extends Deadline On Arana Buyout In Hopes Of Making The Aussie Biotech A Wholly Owned Subsidiary

PERTH, Australia - Cephalon International Holdings has extended its deadline to June 15 for its acquisition of Australian biotech Arana shares in hopes of gaining 90 percent control of the target company, and then transforming it into a wholly owned subsidiary